Latest Breaking News On - Adrian ebner - Page 1 : vimarsana.com

Obvius Robotics' Certa Access System Used in FIH Procedures

June 8, 2023—Obvius Robotics, Inc. announced the completion of the first-in-human (FIH) cases with the company’s Certa percutaneous access

OBVIUS Robotics Announces Completion of Successful First-In-Human Cases

WESTON, Fla: Obvius Robotics, Inc., a medical device company that has developed an innovative technology platform for performing percutaneous access, today announced the successful completion of its first human cases.

Obvius Robotics completes first human cases with Certa system

Obvius Robotics announced today that it successfully completed the first human cases with its Certa Access System.

OBVIUS Robotics™ Announces Completion of Successful First-In-Human Cases

U.S. Patent for Bioelectric Expression of Klotho, a Key

Mission Viejo, California, United States, Oct. 20, 2022 (GLOBE NEWSWIRE) Leonhardt Ventures, LLC  is pleased to announce the United States Patent and.

U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures

Supira Medical Announces Successful First-in-Human Use of its Next Generation Percutaneous Ventricular Assist Device

Three leading U.S. interventional cardiologists attend initial cases as company prepares to expand its clinical program 

SUPIRA MEDICAL ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS NEXT GENERATION PERCUTANEOUS VENTRICULAR ASSIST DEVICE

 Three leading U.S. interventional cardiologists attend initial cases as company prepares to expand its clinical programLOS GATOS, Calif., Sept. 1.

Supira Medical announces first in-human use of pVAD

Supira Medical announced today that it initiated the first-in-human clinical study of its percutaneous ventricular assist device (pVAD).

Latin America's Landscape For Medtech Clinical Trials

This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America,.